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Genetic analyses of autoimmune diseases have revealed
hundreds of disease-associated DNA variants, but
the identity and function of the causal variants are
understudied and warrant deeper mechanistic studies.
Here, we highlight methods for deciphering how alleles
that are associated with autoimmune disease alter the
human immune system, and suggest strategies for
future autoimmune genetic research.In what is the largest bioresource for immune cell phe-The challenge
The genetic mechanisms underlying human auto-
immune diseases remain elusive for many reasons: the
causal alleles or genes are often not known; the effects
of each allele on gene function have often not been
elucidated, especially as most alleles lie in less-well-
understood non-coding regions; the impact of individual
variants may be weak; and unknown environmental fac-
tors may be needed to provoke the effects of specific
alleles. To address these deficiencies in our knowledge,
studies of risk alleles will first need to define the roles of
candidate variants in specific immune responses, and in
time, in disease initiation, maintenance, and progression.
Here, we highlight recent systematic approaches for
discovering how human common genetic variants and
disease-associated risk alleles alter the molecular and
cellular functions of immune cells.
How alleles affect the composition of immune
cells in the blood
Three recent studies have sought to reveal the contribu-
tions of both genetics and the environment on abundance
and activation markers of different cell populations in the
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flow cytometry. They discovered 13 loci that are associated
with these phenotypes, including: the CD39 locus, which
affects the number of CD39+ regulatory T cells and their
function; HNRPLL single nucleotide polymorphisms
(SNPs) that are associated with the relative abundance of
naïve and memory T cells; and several loci that are associ-
ated with multiple traits, such as variants in the HLA class
I locus that affect the prevalence of multiple CD8 T-cell
subsets.
notypes, Roederer et al. [2] list ~78,000 cell phenotypes
found in 669 females who are twins. From among these
phenotypes, 151 of the most highly heritable or biologic-
ally interesting traits were selected for genetic associ-
ation testing. From this analysis, Roederer et al. [2]
found 11 genetic loci that explained ~36 % of the herit-
ability of 19 (of the top 151) heritable immune traits.
Importantly, many of these loci are associated with auto-
immunity. For example, SNP rs1801274, which was pre-
viously associated with systemic lupus erythematosus,
inflammatory bowel disease, and Crohn’s disease, im-
pacts FCGR2A/CD32 receptor expression in cis, as well
as CD27 and CD161 expression on T cells, generating a
novel and concrete hypothesis for how rs1801274 alters
the immune system in humans. Brodin et al. [3] also
found heritable traits, including the IL12B cytokine and
T-cell subtypes, in a study of 204 immune traits in twins,
but concluded from their findings that most traits are in
fact not heritable. These studies are the first to show sys-
tematically how the composition of the blood is con-
trolled by common alleles, and provide hypotheses for
the actions of risk alleles, which can be further studied
ex vivo or mimicked in mouse models.The impact of common genetic variants on the
activation of immune cells
Numerous studies have considered how common alleles
alter cellular states, as measured by RNA or protein ex-
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focused on cells that are activated in response to specific
environmental stimuli, such as ligation of the T-cell anti-
gen receptor, treatment with cytokines, or treatment
with pathogen components. Examples of interesting
findings include: the rs12805435 variant that causes
IRF7 to have trans effects on interferon-inducible genes
exclusively during influenza infection [4]; a SNP close to
IFNB1 that causes a delayed alteration in the response
to lipopolysaccharide [5]; and an IL2RA SNP that affects
its own expression only in activated T cells [6]. In a
meta-analysis using more than 8000 non-transformed
peripheral blood samples, Westra et al. [7] identified
trans expression quantitative trait loci (eQTLs) that are
relevant to autoimmune diseases, including a lupus-
associated SNP in IKZF1 that affects the expression
of several relevant genes, including C1Q and five
interferon-inducible genes. By teaching us how common
alleles alter immune networks, these studies are generat-
ing testable hypotheses to describe human autoimmune
pathogenesis that will guide research in the field and
suggest new therapeutic concepts.
Integrating datasets to hone in on probable
causal alleles and their cell type-specific function
In addition to analyzing gene expression, some studies
have considered how disease alleles localize within open
chromatin. Maurano et al. [8] intersected autoimmune
SNPs from genome-wide association studies (GWAS)
with DNase I hypersensitivity sites (DHSs) from many
cell types, and found that 93.2 % of the overlapping
SNPs landed in known transcription factor motifs. These
authors also used chromatin interaction analysis with
paired-end tag sequencing technology (ChIA-PET) to
find that many GWAS variants within DHSs were highly
associated with the activity of distant genes, some of
which were at distances of more than 500 kb from the
transcription start site; these non-coding variants may
underlie phenotype associations in autoimmunity. Like
DHSs, ATAC-seq also finds areas of open chromatin,
but has a faster workflow and reduced sample input, and
we expect it to be useful for epigenomic analysis of large
numbers of patients in future studies.
Farh et al. [9] aimed to pinpoint causal disease variants
near genes of interest by searching for localization of
SNPs in regions of H3K27ac active chromatin in many
cell types, including immune cells [9]. They honed in on
a set of putative causal variants and observed that vari-
ants that were associated with most autoimmune dis-
eases were specifically enriched in active chromatin
from T cells, whereas variants that were associated with
lupus were most enriched in active chromatin from B
cells, T cells, and monocytes. Future studies will enhance
such maps by providing even more comprehensivedatasets of chromatin states across immune cell types.
Rare but important cell types that are likely to play im-
portant roles in autoimmunity, such as follicular helper
T cells and plasmacytoid dendritic cells, should be in-
cluded. These and similar studies [10] that utilize activity
maps of non-coding regions not only help to pinpoint
alleles and their role in specific cell types and conditions,
but also specify which cis elements and cognate factors
are likely to be impacted by variations in the DNA.
These hypotheses bring us closer to a mechanistic model
of how variants affect gene expression in specific cells
and conditions, which can then be validated using
modern perturbation tools such as CRISPR-mediated
mutagenesis. By finding out which transcription factor
(TF)–DNA interactions are affected by risk alleles, we
will be able to predict which pathways (upstream of the
TF) should be targeted for restoration of normal im-
mune functions.What about the patients?
The above studies focus on healthy individuals to avoid
the complex effects of disease and treatment. And yet,
some variants may only show their effects in the unique
context of the patient with disease, as a result of deregu-
lated signaling, positive feedback loops, and cellular
crosstalk between pathogenic cell types. Furthermore,
the open chromatin of patients might reveal permissive
areas where disease variants could reside. An analysis of
gene expression and chromatin states in sorted cell types
from patients should be performed to reveal disease-
specific effects and to link these phenotypes with geno-
types. To ensure that patients are controlled for the
treatment of their disease, studies could piggyback on a
clinical trial, during which patient treatments would typ-
ically be more uniform than those given to the general
patient population. In the future, personalized therapeu-
tics and prophylactic measures could target gene prod-
ucts or pathways on the basis of information derived
from a patient’s cellular epigenomic landscape, as de-
fined by open chromatin and the patient’s risk variants
that localize to this open chromatin. Understanding the
genetic architecture in autoimmunity is important to de-
rive such target genes, and pathways and bioresources
such as those outlined by Roederer et al. [2] could aid in
the generation of new hypotheses to delineate disease
mechanisms underlying autoimmunity. With improve-
ments in tools and careful cohort selection, it is time to
bring the study of common genetic variations and their
effects on phenotype back to the patient, ultimately in
the context of clinical trials.
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